TURMERIC

TURMERIC was reported 5338 times

TURMERIC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD IMMUNOGLOBULIN E DECREASED 3 0.0186
1 BLOOD ZINC DECREASED 3 0.0165
2 MUSCLE SWELLING 6 0.0065
3 CARTILAGE ATROPHY 4 0.0050
4 ALLERGIC OEDEMA 3 0.0046
5 TRIGGER FINGER 18 0.0044
6 BRONCHIAL WALL THICKENING 3 0.0042
7 LIGHT CHAIN ANALYSIS INCREASED 4 0.0039
8 CHRONIC FATIGUE SYNDROME 5 0.0036
9 TENDON DISORDER 23 0.0035
10 PRODUCT CONTAMINATION MICROBIAL 4 0.0034
11 REFLUX GASTRITIS 4 0.0033
12 BLOOD IMMUNOGLOBULIN M DECREASED 3 0.0030
13 INGROWING NAIL 7 0.0030
14 EMOTIONAL POVERTY 5 0.0029
15 DERMAL CYST 7 0.0028
16 TENDON PAIN 21 0.0028
17 ESSENTIAL HYPERTENSION 5 0.0027
18 HYPERACUSIS 10 0.0027
19 POTENTIATING DRUG INTERACTION 9 0.0027
20 CARBOHYDRATE ANTIGEN 125 INCREASED 9 0.0026
21 JOINT NOISE 5 0.0025
22 LIP PAIN 7 0.0024
23 WOUND HAEMORRHAGE 9 0.0024
24 SEBORRHOEIC DERMATITIS 4 0.0024
25 ALLERGY TO CHEMICALS 3 0.0024
26 MYOCARDIAL NECROSIS MARKER INCREASED 4 0.0024
27 APPLICATION SITE WARMTH 3 0.0024
28 MILIARIA 4 0.0023
29 BLOOD TESTOSTERONE INCREASED 5 0.0023
30 CERVICAL SPINAL STENOSIS 4 0.0023
31 TEMPOROMANDIBULAR JOINT SYNDROME 6 0.0022
32 CLUMSINESS 6 0.0022
33 AGORAPHOBIA 3 0.0022
34 HYPERKERATOSIS 12 0.0022
35 OESOPHAGEAL SPASM 4 0.0022
36 STOMA SITE ERYTHEMA 4 0.0021
37 TUNNEL VISION 4 0.0021
38 ADRENAL DISORDER 4 0.0021
39 EXOSTOSIS 19 0.0021
40 EARLY SATIETY 4 0.0021
41 CARDIAC FIBRILLATION 3 0.0020
42 EXCESSIVE EYE BLINKING 3 0.0020
43 JOINT CREPITATION 4 0.0020
44 EYELID PAIN 4 0.0020
45 INCREASED TENDENCY TO BRUISE 18 0.0020
46 MENISCUS INJURY 12 0.0019
47 SYNOVIAL CYST 9 0.0019
48 NEUROGENIC BLADDER 4 0.0019
49 FREEZING PHENOMENON 7 0.0019
50 WEIGHT BEARING DIFFICULTY 5 0.0019
51 APPLICATION SITE SCAB 4 0.0019
52 COSTOCHONDRITIS 3 0.0018
53 LIP BLISTER 5 0.0018
54 VITREOUS FLOATERS 18 0.0018
55 STOMA SITE DISCHARGE 5 0.0018
56 THYROID MASS 7 0.0018
57 MIDDLE EAR EFFUSION 4 0.0018
58 ROTATOR CUFF SYNDROME 23 0.0018
59 CONTRAINDICATED PRODUCT PRESCRIBED 3 0.0018
60 FORCED EXPIRATORY VOLUME DECREASED 5 0.0018
61 WOUND COMPLICATION 6 0.0017
62 VARICOSE VEIN 9 0.0017
63 VITAMIN B12 DECREASED 5 0.0017
64 MICTURITION DISORDER 6 0.0017
65 ROSACEA 8 0.0017
66 FOOD INTERACTION 3 0.0017
67 PAINFUL RESPIRATION 4 0.0017
68 SKIN FRAGILITY 4 0.0016
69 VITAMIN D DEFICIENCY 16 0.0016
70 BODY TEMPERATURE ABNORMAL 3 0.0016
71 FOOT OPERATION 8 0.0016
72 TENDONITIS 25 0.0016
73 CHAPPED LIPS 7 0.0016
74 AURA 3 0.0016
75 CYSTOID MACULAR OEDEMA 3 0.0016
76 VASODILATATION 4 0.0016
77 SNORING 6 0.0016
78 LIGAMENT RUPTURE 7 0.0016
79 BILE DUCT OBSTRUCTION 3 0.0016
80 ENDODONTIC PROCEDURE 4 0.0016
81 BLADDER PAIN 5 0.0016
82 POLYMYALGIA RHEUMATICA 5 0.0016
83 HAIR TEXTURE ABNORMAL 21 0.0016
84 TENDON RUPTURE 19 0.0015
85 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
86 BRADYPHRENIA 10 0.0015
87 CARPAL TUNNEL SYNDROME 21 0.0015
88 INTRACRANIAL ANEURYSM 6 0.0015
89 EAR HAEMORRHAGE 3 0.0015
90 NEURALGIA 36 0.0015
91 TONGUE ULCERATION 5 0.0015
92 PERIPHERAL VENOUS DISEASE 6 0.0015
93 WRONG PATIENT RECEIVED MEDICATION 4 0.0015
94 JAW DISORDER 8 0.0015
95 RHEUMATOID NODULE 4 0.0015
96 RED BLOOD CELL COUNT INCREASED 4 0.0014
97 JOINT EFFUSION 10 0.0014
98 FULL BLOOD COUNT DECREASED 29 0.0014
99 FORMICATION 10 0.0014
100 TRICHORRHEXIS 4 0.0014
101 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
102 HANGOVER 5 0.0014
103 TONGUE DISCOMFORT 6 0.0014
104 NECK MASS 4 0.0014
105 JOINT LOCK 4 0.0014
106 NERVE COMPRESSION 13 0.0014
107 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
108 VITAMIN D DECREASED 12 0.0014
109 HAIR COLOUR CHANGES 17 0.0014
110 FEELING OF BODY TEMPERATURE CHANGE 8 0.0014
111 STRABISMUS 4 0.0014
112 DECREASED INTEREST 8 0.0014
113 DANDRUFF 3 0.0014
114 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
115 FOOD CRAVING 7 0.0013
116 COMPUTERISED TOMOGRAM ABNORMAL 3 0.0013
117 REBOUND ACID HYPERSECRETION 4 0.0013
118 URINE ABNORMALITY 6 0.0013
119 IRITIS 4 0.0013
120 PARANASAL SINUS HYPERSECRETION 5 0.0013
121 HAIR GROWTH ABNORMAL 9 0.0013
122 MUSCULOSKELETAL PAIN 68 0.0013
123 NEPHROGENIC ANAEMIA 6 0.0013
124 PRE-EXISTING CONDITION IMPROVED 8 0.0013
125 MYOCLONUS 15 0.0013
126 PNEUMONIA VIRAL 4 0.0013
127 POOR QUALITY SLEEP 27 0.0013
128 SEROTONIN SYNDROME 24 0.0012
129 OCULAR DISCOMFORT 14 0.0012
130 EYE INFECTION 14 0.0012
131 BLOOD IMMUNOGLOBULIN E INCREASED 3 0.0012
132 GOITRE 5 0.0012
133 CARTILAGE INJURY 3 0.0012
134 LISTLESS 4 0.0012
135 NEUROPATHY PERIPHERAL 114 0.0012
136 LIMB DISCOMFORT 37 0.0012
137 PLANTAR FASCIITIS 4 0.0012
138 LYMPHOCYTE COUNT DECREASED 21 0.0012
139 ENERGY INCREASED 7 0.0012
140 BUNDLE BRANCH BLOCK LEFT 5 0.0012
141 MUSCLE TIGHTNESS 19 0.0012
142 TOOTH DISORDER 26 0.0012
143 BLOOD CHLORIDE DECREASED 3 0.0012
144 MUSCULOSKELETAL CHEST PAIN 18 0.0012
145 CONCUSSION 9 0.0012
146 SQUAMOUS CELL CARCINOMA OF SKIN 7 0.0012
147 TACHYPHRENIA 4 0.0012
148 MULTIPLE ALLERGIES 9 0.0011
149 TONGUE DISCOLOURATION 5 0.0011
150 SCAB 13 0.0011
151 ONYCHOMYCOSIS 5 0.0011
152 MUSCLE CONTRACTIONS INVOLUNTARY 4 0.0011
153 EAR PAIN 22 0.0011
154 MUSCLE TWITCHING 26 0.0011
155 DIVERTICULUM 8 0.0011
156 BLOOD COUNT ABNORMAL 17 0.0011
157 NASAL DRYNESS 7 0.0011
158 SPONDYLITIS 4 0.0011
159 HICCUPS 9 0.0011
160 HAIR DISORDER 9 0.0011
161 GASTROINTESTINAL PAIN 12 0.0011
162 SPINAL COMPRESSION FRACTURE 9 0.0011
163 CHOLECYSTITIS INFECTIVE 3 0.0011
164 APPLICATION SITE VESICLES 7 0.0011
165 BURNING SENSATION 75 0.0011
166 SCIATICA 17 0.0011
167 SKIN TIGHTNESS 5 0.0011
168 SKIN ABRASION 5 0.0011
169 PARANASAL SINUS DISCOMFORT 4 0.0011
170 FACIAL PARALYSIS 9 0.0011
171 FEELING JITTERY 20 0.0010
172 SKIN MASS 7 0.0010
173 BLOOD MAGNESIUM DECREASED 9 0.0010
174 FINE MOTOR SKILL DYSFUNCTION 3 0.0010
175 PRODUCT LABEL ISSUE 7 0.0010
176 BLOOD POTASSIUM DECREASED 31 0.0010
177 NAIL DISORDER 9 0.0010
178 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
179 GROIN PAIN 9 0.0010
180 SPINAL PAIN 12 0.0010
181 TINNITUS 47 0.0010
182 ONYCHOCLASIS 7 0.0010
183 SKIN ODOUR ABNORMAL 4 0.0010
184 PRODUCT DOSE OMISSION 66 0.0010
185 SINUS HEADACHE 6 0.0010
186 NASAL DISCOMFORT 8 0.0010
187 INTERVERTEBRAL DISC PROTRUSION 22 0.0010
188 WHITE BLOOD CELL COUNT DECREASED 109 0.0010
189 AGEUSIA 25 0.0010
190 FLUID INTAKE REDUCED 5 0.0010
191 DEFAECATION URGENCY 7 0.0010
192 RESTLESS LEGS SYNDROME 18 0.0010
193 VAGINAL DISCHARGE 10 0.0010
194 APPLICATION SITE DISCOLOURATION 4 0.0010
195 BACK DISORDER 16 0.0010
196 RED BLOOD CELL COUNT DECREASED 28 0.0010
197 JOINT RANGE OF MOTION DECREASED 13 0.0010
198 SPINAL STENOSIS 4 0.0010
199 NIGHT SWEATS 31 0.0010
200 HEAD DISCOMFORT 17 0.0010
201 PHOTOPHOBIA 18 0.0010
202 SENSITIVITY TO WEATHER CHANGE 5 0.0009
203 ABDOMINAL ADHESIONS 3 0.0009
204 MUSCULOSKELETAL DISORDER 18 0.0009
205 OSTEOARTHRITIS 40 0.0009
206 SUNBURN 7 0.0009
207 BODY HEIGHT DECREASED 10 0.0009
208 FOOD POISONING 5 0.0009
209 DIZZINESS POSTURAL 9 0.0009
210 PRODUCT RESIDUE PRESENT 5 0.0009
211 SINUSITIS 95 0.0009
212 MUSCLE SPASMS 170 0.0009
213 MUSCLE STRAIN 8 0.0009
214 IMMOBILE 4 0.0009
215 BREAST ENLARGEMENT 3 0.0009
216 MELANOCYTIC NAEVUS 4 0.0009
217 LIGAMENT SPRAIN 9 0.0009
218 ASTHENOPIA 5 0.0009
219 PRODUCT FORMULATION ISSUE 6 0.0009
220 SINUS DISORDER 18 0.0009
221 PROSTATIC DISORDER 5 0.0009
222 MUSCULOSKELETAL STIFFNESS 79 0.0009
223 MUSCULAR WEAKNESS 102 0.0009
224 NECK PAIN 50 0.0009
225 BREAST MASS 6 0.0009
226 ORAL PAIN 20 0.0009
227 GAIT DISTURBANCE 170 0.0009
228 ULCER HAEMORRHAGE 6 0.0009
229 EYE PAIN 50 0.0009
230 APPLICATION SITE DRYNESS 3 0.0009
231 FURUNCLE 7 0.0009
232 DRUG EFFECT INCOMPLETE 32 0.0009
233 BALANCE DISORDER 76 0.0009
234 PANIC ATTACK 32 0.0009
235 ATRIAL FLUTTER 7 0.0009
236 JOINT STIFFNESS 23 0.0009
237 HELICOBACTER INFECTION 9 0.0009
238 MICTURITION URGENCY 10 0.0009
239 GASTRIC DISORDER 30 0.0009
240 HYPOAESTHESIA 130 0.0009
241 LARGE INTESTINE POLYP 6 0.0009
242 EYE DISCHARGE 9 0.0009
243 ARTHRITIS 68 0.0009
244 FEELING COLD 24 0.0009
245 POST PROCEDURAL INFECTION 7 0.0009
246 HYPERAESTHESIA 7 0.0009
247 URINE ODOUR ABNORMAL 5 0.0008
248 VAGINAL INFECTION 4 0.0008
249 CYSTITIS 27 0.0008
250 RASH PAPULAR 19 0.0008
251 FLATULENCE 48 0.0008
252 JOINT INJURY 18 0.0008
253 HAEMORRHAGIC DIATHESIS 3 0.0008
254 THERAPY CESSATION 43 0.0008
255 IMMUNE SYSTEM DISORDER 11 0.0008
256 TOOTH INFECTION 11 0.0008
257 WRIST FRACTURE 10 0.0008
258 BASAL CELL CARCINOMA 13 0.0008
259 FATIGUE 645 0.0008
260 PLATELET COUNT ABNORMAL 5 0.0008
261 FINGER DEFORMITY 4 0.0008
262 FAECES SOFT 6 0.0008
263 THERAPEUTIC RESPONSE UNEXPECTED 37 0.0008
264 BURSITIS 10 0.0008
265 NOCTURIA 10 0.0008
266 INSOMNIA 219 0.0008
267 QUALITY OF LIFE DECREASED 11 0.0008
268 PSORIATIC ARTHROPATHY 33 0.0008
269 APPLICATION SITE BURN 4 0.0008
270 PANCREATIC DISORDER 4 0.0008
271 PERIPHERAL SWELLING 125 0.0008
272 CEREBRAL DISORDER 6 0.0008
273 NERVE INJURY 9 0.0008
274 SCOLIOSIS 5 0.0008
275 CYST 10 0.0008
276 BLADDER DISORDER 8 0.0008
277 ABDOMINAL TENDERNESS 4 0.0008
278 SPINAL OSTEOARTHRITIS 7 0.0008
279 HYPOAESTHESIA ORAL 12 0.0008
280 PLASMA CELL MYELOMA 31 0.0008
281 AUTOIMMUNE THYROIDITIS 3 0.0008
282 MOBILITY DECREASED 57 0.0008
283 IMPAIRED DRIVING ABILITY 9 0.0008
284 ORAL DISCOMFORT 11 0.0008
285 PHOTOPSIA 5 0.0008
286 MUSCLE ATROPHY 10 0.0008
287 RHINORRHOEA 51 0.0008
288 SCREAMING 5 0.0008
289 FACIAL PAIN 7 0.0008
290 BOWEL MOVEMENT IRREGULARITY 6 0.0008
291 CLAVICLE FRACTURE 3 0.0008
292 PRODUCT SUBSTITUTION ISSUE 45 0.0008
293 GOUT 14 0.0008
294 INITIAL INSOMNIA 8 0.0008
295 PAIN IN EXTREMITY 229 0.0008
296 MADAROSIS 9 0.0008
297 TEMPERATURE INTOLERANCE 8 0.0008
298 CARDIAC FLUTTER 5 0.0008
299 FAECES HARD 3 0.0008
300 VENTRICULAR EXTRASYSTOLES 8 0.0008
301 GASTROOESOPHAGEAL REFLUX DISEASE 62 0.0008
302 BRONCHITIS 57 0.0008
303 CANDIDA INFECTION 13 0.0008
304 PALPITATIONS 90 0.0008
305 SOMNAMBULISM 5 0.0008
306 BLOOD ALBUMIN DECREASED 6 0.0008
307 RENAL CYST 6 0.0008
308 JOINT SWELLING 91 0.0008
309 DYSSTASIA 22 0.0008
310 CEREBRAL ATROPHY 3 0.0008
311 HEART RATE IRREGULAR 17 0.0008
312 ARTHRALGIA 312 0.0007
313 COGNITIVE DISORDER 35 0.0007
314 BLEPHARITIS 3 0.0007
315 PRODUCT SIZE ISSUE 4 0.0007
316 POLLAKIURIA 31 0.0007
317 HYPOPHAGIA 19 0.0007
318 FRUSTRATION TOLERANCE DECREASED 6 0.0007
319 STOMATITIS 45 0.0007
320 BRUXISM 4 0.0007
321 DRY EYE 37 0.0007
322 FREQUENT BOWEL MOVEMENTS 20 0.0007
323 DRY MOUTH 60 0.0007
324 PULMONARY MASS 11 0.0007
325 IMMUNODEFICIENCY 11 0.0007
326 GASTRIC ULCER 14 0.0007
327 SLEEP APNOEA SYNDROME 14 0.0007
328 HYPERSOMNIA 21 0.0007
329 MUSCLE SPASTICITY 9 0.0007
330 HOT FLUSH 55 0.0007
331 CORONARY ARTERY OCCLUSION 10 0.0007
332 ABASIA 18 0.0007
333 CENTRAL NERVOUS SYSTEM LESION 10 0.0007
334 PHOTOSENSITIVITY REACTION 12 0.0007
335 PROSTATIC SPECIFIC ANTIGEN INCREASED 10 0.0007
336 ERUCTATION 14 0.0007
337 LYMPHOEDEMA 5 0.0007
338 VERTIGO 44 0.0007
339 FOOT DEFORMITY 8 0.0007
340 HIP ARTHROPLASTY 11 0.0007
341 GAIT INABILITY 24 0.0007
342 HEART RATE ABNORMAL 4 0.0007
343 EXTRASYSTOLES 5 0.0007
344 BACK PAIN 166 0.0007
345 ALOPECIA 140 0.0007
346 KNEE ARTHROPLASTY 15 0.0007
347 DYSPEPSIA 70 0.0007
348 SEASONAL ALLERGY 10 0.0007
349 CONSTIPATION 154 0.0007
350 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
351 HAND FRACTURE 5 0.0007
352 PERONEAL NERVE PALSY 4 0.0007
353 MENTAL IMPAIRMENT 17 0.0007
354 BONE PAIN 41 0.0007
355 NEUROLOGICAL SYMPTOM 4 0.0007
356 PARAESTHESIA 110 0.0007
357 NEOPLASM 8 0.0007
358 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
359 NEOPLASM PROGRESSION 24 0.0007
360 TASTE DISORDER 14 0.0007
361 SKIN WARM 4 0.0007
362 MOTOR DYSFUNCTION 7 0.0007
363 SLUGGISHNESS 7 0.0007
364 FOOT FRACTURE 13 0.0007
365 APATHY 10 0.0007
366 CONTUSION 66 0.0007
367 INTENTIONAL UNDERDOSE 5 0.0007
368 MEMORY IMPAIRMENT 94 0.0007
369 ORAL DISORDER 5 0.0007
370 EAR DISCOMFORT 7 0.0007
371 RIB FRACTURE 14 0.0007
372 INFLAMMATION 35 0.0007
373 LABORATORY TEST ABNORMAL 20 0.0007
374 EAR INFECTION 18 0.0007
375 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
376 ARTHROPOD BITE 5 0.0007
377 BLOOD IRON DECREASED 8 0.0007
378 UNEVALUABLE EVENT 51 0.0007
379 BLOOD PRESSURE INCREASED 103 0.0007
380 PAIN IN JAW 19 0.0007
381 ODYNOPHAGIA 4 0.0007
382 GLOSSODYNIA 15 0.0007
383 OROPHARYNGEAL PAIN 62 0.0007
384 WEIGHT FLUCTUATION 7 0.0007
385 PRODUCT ODOUR ABNORMAL 7 0.0007
386 DEPRESSION 152 0.0007
387 ANAL INCONTINENCE 6 0.0007
388 SINUS CONGESTION 9 0.0007
389 ORAL HERPES 13 0.0007
390 SLEEP DISORDER 47 0.0007
391 PSYCHOMOTOR HYPERACTIVITY 11 0.0007
392 DRUG EFFECT DELAYED 3 0.0007
393 AMNESIA 43 0.0007
394 CRYING 24 0.0007
395 DERMATITIS ACNEIFORM 4 0.0007
396 MULTIPLE SCLEROSIS RELAPSE 45 0.0007
397 EAR DISORDER 3 0.0007
398 IMPAIRED WORK ABILITY 14 0.0007
399 DIPLOPIA 17 0.0007
400 MOVEMENT DISORDER 21 0.0007
401 PRESCRIBED UNDERDOSE 13 0.0007
402 NERVOUSNESS 34 0.0007
403 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
404 ARTHROPATHY 36 0.0006
405 FEELING ABNORMAL 155 0.0006
406 ARTHRITIS INFECTIVE 3 0.0006
407 HEPATIC ENZYME INCREASED 44 0.0006
408 HEPATIC STEATOSIS 12 0.0006
409 SKIN LACERATION 7 0.0006
410 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 15 0.0006
411 FEELING OF DESPAIR 3 0.0006
412 URINARY INCONTINENCE 19 0.0006
413 LACERATION 6 0.0006
414 STAPHYLOCOCCAL INFECTION 21 0.0006
415 FUNGAL INFECTION 21 0.0006
416 APHASIA 19 0.0006
417 GINGIVAL PAIN 5 0.0006
418 FOREIGN BODY SENSATION IN EYES 4 0.0006
419 HEART RATE DECREASED 22 0.0006
420 PARAESTHESIA ORAL 9 0.0006
421 MYALGIA 106 0.0006
422 BLISTER 35 0.0006
423 BLOOD CALCIUM DECREASED 7 0.0006
424 BLOOD CHOLESTEROL INCREASED 29 0.0006
425 VISUAL IMPAIRMENT 77 0.0006
426 HERNIA 12 0.0006
427 INCOHERENT 4 0.0006
428 RASH GENERALISED 16 0.0006
429 HIATUS HERNIA 8 0.0006
430 MUSCLE DISORDER 5 0.0006
431 FIBROMYALGIA 15 0.0006
432 HAEMORRHOIDS 12 0.0006
433 PLATELET COUNT INCREASED 8 0.0006
434 NODULE 8 0.0006
435 PROCEDURAL PAIN 17 0.0006
436 CHOLECYSTECTOMY 7 0.0006
437 KNEE OPERATION 6 0.0006
438 IMPAIRED HEALING 20 0.0006
439 BEDRIDDEN 8 0.0006
440 ASTHENIA 228 0.0006
441 HEART RATE INCREASED 60 0.0006
442 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
443 CATARACT 36 0.0006
444 DIARRHOEA 390 0.0006
445 MUSCLE INJURY 5 0.0006
446 UPPER LIMB FRACTURE 12 0.0006
447 DEHYDRATION 80 0.0006
448 RHEUMATOID ARTHRITIS 68 0.0006
449 SWELLING 56 0.0006
450 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
451 PAIN OF SKIN 16 0.0006
452 RASH PRURITIC 32 0.0006
453 THINKING ABNORMAL 11 0.0006
454 URINARY TRACT INFECTION 100 0.0006
455 MACULAR DEGENERATION 7 0.0006
456 GINGIVAL BLEEDING 8 0.0006
457 HYPERLIPIDAEMIA 7 0.0006
458 ECCHYMOSIS 4 0.0006
459 DYSPHONIA 34 0.0006
460 COLITIS 22 0.0006
461 ANXIETY 165 0.0006
462 BLOOD URINE PRESENT 11 0.0006
463 CARDIAC MURMUR 5 0.0006
464 DIVERTICULITIS 16 0.0006
465 SKIN SWELLING 5 0.0006
466 TENDERNESS 6 0.0006
467 INCREASED APPETITE 11 0.0006
468 PETECHIAE 6 0.0006
469 DISTURBANCE IN ATTENTION 31 0.0006
470 HERPES ZOSTER 33 0.0006
471 WHITE BLOOD CELL COUNT INCREASED 22 0.0006
472 INJECTION SITE URTICARIA 14 0.0006
473 BLOOD CALCIUM INCREASED 5 0.0006
474 GASTRITIS 15 0.0006
475 PAIN 350 0.0006
476 DRUG ADMINISTERED AT INAPPROPRIATE SITE 6 0.0006
477 HEAD INJURY 18 0.0006
478 SMALL INTESTINAL OBSTRUCTION 7 0.0006
479 IMMUNOSUPPRESSION 5 0.0006
480 SKIN DISCOLOURATION 26 0.0006
481 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 27 0.0006
482 KIDNEY INFECTION 11 0.0006
483 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
484 COMPRESSION FRACTURE 3 0.0006
485 LIVER FUNCTION TEST INCREASED 12 0.0006
486 MIGRAINE 53 0.0006
487 ERYTHEMA OF EYELID 3 0.0006
488 VISION BLURRED 76 0.0006
489 TONGUE DISORDER 4 0.0006
490 TOOTHACHE 10 0.0006
491 BIPOLAR DISORDER 6 0.0006
492 HYPOKINESIA 8 0.0006
493 LIP DRY 5 0.0005
494 HEADACHE 345 0.0005
495 FALL 183 0.0005
496 CLOSTRIDIUM DIFFICILE INFECTION 12 0.0005
497 SPINAL FRACTURE 11 0.0005
498 DEPRESSED MOOD 29 0.0005
499 OCULAR HYPERAEMIA 26 0.0005
500 WITHDRAWAL SYNDROME 23 0.0005
501 EYE DISORDER 18 0.0005
502 DECREASED APPETITE 127 0.0005
503 ASPARTATE AMINOTRANSFERASE INCREASED 29 0.0005
504 MULTIPLE SCLEROSIS 26 0.0005
505 DENTAL CARIES 6 0.0005
506 UROSEPSIS 5 0.0005
507 IRON DEFICIENCY ANAEMIA 5 0.0005
508 CARDIOMYOPATHY 8 0.0005
509 UPPER RESPIRATORY TRACT INFECTION 25 0.0005
510 EYE SWELLING 20 0.0005
511 LOCALISED INFECTION 13 0.0005
512 RESPIRATORY TRACT INFECTION 14 0.0005
513 ALANINE AMINOTRANSFERASE INCREASED 33 0.0005
514 TREMOR 89 0.0005
515 WEIGHT INCREASED 120 0.0005
516 EYE PRURITUS 18 0.0005
517 MIDDLE INSOMNIA 10 0.0005
518 INFLUENZA LIKE ILLNESS 44 0.0005
519 FLUSHING 54 0.0005
520 BLOOD SODIUM DECREASED 10 0.0005
521 PAROSMIA 4 0.0005
522 LACRIMATION INCREASED 16 0.0005
523 HIP FRACTURE 17 0.0005
524 DYSMENORRHOEA 7 0.0005
525 SPINAL DISORDER 5 0.0005
526 CHRONIC KIDNEY DISEASE 40 0.0005
527 CARDIAC VALVE DISEASE 3 0.0005
528 RECALLED PRODUCT ADMINISTERED 5 0.0005
529 DIZZINESS 261 0.0005
530 MUSCULOSKELETAL DISCOMFORT 9 0.0005
531 PROCEDURAL COMPLICATION 4 0.0005
532 EXERCISE TOLERANCE DECREASED 3 0.0005
533 THYROID DISORDER 8 0.0005
534 CHOLELITHIASIS 17 0.0005
535 HYPERCHOLESTEROLAEMIA 5 0.0005
536 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
537 CELLULITIS 26 0.0005
538 APHTHOUS ULCER 4 0.0005
539 LIMB INJURY 14 0.0005
540 ABDOMINAL DISCOMFORT 86 0.0005
541 SPLENOMEGALY 6 0.0005
542 ADVERSE DRUG REACTION 46 0.0005
543 DYSGEUSIA 38 0.0005
544 HYPOACUSIS 22 0.0005
545 GASTROINTESTINAL INFLAMMATION 4 0.0005
546 COLD SWEAT 9 0.0005
547 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
548 SKIN DISORDER 17 0.0005
549 THERAPY CHANGE 5 0.0005
550 CHEST DISCOMFORT 52 0.0005
551 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 36 0.0005
552 ABDOMINAL PAIN UPPER 104 0.0005
553 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
554 THIRST 9 0.0005
555 RESPIRATORY TRACT CONGESTION 8 0.0005
556 CHILLS 59 0.0005
557 CARDIAC PACEMAKER INSERTION 3 0.0005
558 SKIN ULCER 13 0.0005
559 OBESITY 8 0.0005
560 APPLICATION SITE PAIN 11 0.0005
561 SENSORY DISTURBANCE 8 0.0005
562 WEIGHT DECREASED 139 0.0005
563 PSORIASIS 65 0.0005
564 PLATELET COUNT DECREASED 53 0.0005
565 THROMBOSIS 40 0.0005
566 EPISTAXIS 37 0.0005
567 NASOPHARYNGITIS 91 0.0005
568 DISCOMFORT 30 0.0005
569 DRUG LEVEL DECREASED 5 0.0005
570 CHROMATURIA 11 0.0005
571 SPINAL OPERATION 6 0.0005
572 EYE IRRITATION 28 0.0005
573 RASH MACULAR 17 0.0005
574 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
575 FEMUR FRACTURE 15 0.0005
576 HYPERBILIRUBINAEMIA 5 0.0005
577 NAUSEA 382 0.0005
578 TOOTH EXTRACTION 6 0.0005
579 RASH ERYTHEMATOUS 23 0.0005
580 THROAT TIGHTNESS 13 0.0005
581 LYMPHADENOPATHY 17 0.0005
582 NEPHROLITHIASIS 22 0.0005
583 SECRETION DISCHARGE 6 0.0005
584 ABDOMINAL DISTENSION 50 0.0005
585 INTESTINAL OBSTRUCTION 18 0.0005
586 MOOD ALTERED 13 0.0005
587 SCRATCH 5 0.0005
588 FLUID RETENTION 24 0.0005
589 RENAL PAIN 5 0.0005
590 ABNORMAL DREAMS 13 0.0005
591 INTRAOCULAR PRESSURE INCREASED 6 0.0005
592 RETCHING 10 0.0005
593 POST PROCEDURAL COMPLICATION 9 0.0005
594 MYDRIASIS 6 0.0005
595 COUGH 131 0.0005
596 SKIN HYPERPIGMENTATION 4 0.0005
597 HYSTERECTOMY 4 0.0005
598 OSTEOPENIA 7 0.0005
599 SWELLING FACE 30 0.0005
600 LOCAL SWELLING 8 0.0005
601 PULMONARY THROMBOSIS 5 0.0005
602 APPLICATION SITE ERYTHEMA 12 0.0005
603 DYSGRAPHIA 3 0.0005
604 WHEEZING 27 0.0005
605 GRIP STRENGTH DECREASED 4 0.0005
606 DISORIENTATION 18 0.0005
607 TOOTH FRACTURE 5 0.0005
608 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
609 BLOOD PRESSURE ABNORMAL 9 0.0005
610 APPETITE DISORDER 3 0.0005
611 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
612 HYPERHIDROSIS 58 0.0004
613 EYE HAEMORRHAGE 6 0.0004
614 GALLBLADDER DISORDER 8 0.0004
615 MALIGNANT MELANOMA 6 0.0004
616 ANGER 15 0.0004
617 NASAL CONGESTION 26 0.0004
618 UVEITIS 6 0.0004
619 ATRIAL FIBRILLATION 43 0.0004
620 PELVIC PAIN 8 0.0004
621 PRODUCTIVE COUGH 21 0.0004
622 SPEECH DISORDER 23 0.0004
623 RASH 191 0.0004
624 INTERNAL HAEMORRHAGE 5 0.0004
625 PERIPHERAL COLDNESS 6 0.0004
626 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
627 PRURITUS 167 0.0004
628 DRY SKIN 58 0.0004
629 HYPERTENSION 92 0.0004
630 NIGHTMARE 15 0.0004
631 PULMONARY HYPERTENSION 9 0.0004
632 CONJUNCTIVITIS 8 0.0004
633 COORDINATION ABNORMAL 6 0.0004
634 CONDITION AGGRAVATED 130 0.0004
635 BLINDNESS UNILATERAL 6 0.0004
636 FEELING HOT 26 0.0004
637 THROAT IRRITATION 19 0.0004
638 SPUTUM DISCOLOURED 4 0.0004
639 INJECTION SITE REACTION 29 0.0004
640 BLOOD PRESSURE DECREASED 28 0.0004
641 CHEST PAIN 78 0.0004
642 PRODUCT PACKAGING ISSUE 4 0.0004
643 HAEMOGLOBIN DECREASED 43 0.0004
644 DRUG DOSE OMISSION 69 0.0004
645 BLOOD PRESSURE FLUCTUATION 10 0.0004
646 AFFECT LABILITY 4 0.0004
647 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
648 AUTOIMMUNE DISORDER 4 0.0004
649 FEAR 11 0.0004
650 PHARYNGEAL SWELLING 4 0.0004
651 DRUG EFFECT DECREASED 22 0.0004
652 COELIAC DISEASE 4 0.0004
653 HYPOTHYROIDISM 13 0.0004
654 BLINDNESS TRANSIENT 3 0.0004
655 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
656 HOSPICE CARE 4 0.0004
657 SKIN HAEMORRHAGE 6 0.0004
658 INFLUENZA 45 0.0004
659 SOMNOLENCE 81 0.0004
660 CONFUSIONAL STATE 65 0.0004
661 SKIN LESION 11 0.0004
662 HYPOTONIA 4 0.0004
663 THERAPY NON-RESPONDER 18 0.0004
664 DYSPHAGIA 38 0.0004
665 OVARIAN CYST 4 0.0004
666 LETHARGY 23 0.0004
667 IRRITABILITY 24 0.0004
668 BREAST TENDERNESS 3 0.0004
669 ABDOMINAL PAIN LOWER 10 0.0004
670 FEEDING DISORDER 8 0.0004
671 OEDEMA PERIPHERAL 48 0.0004
672 INJECTION SITE IRRITATION 5 0.0004
673 TOOTH ABSCESS 4 0.0004
674 LIP SWELLING 13 0.0004
675 URINARY RETENTION 13 0.0004
676 OSTEOPOROSIS 16 0.0004
677 DELUSION 6 0.0004
678 NERVOUS SYSTEM DISORDER 12 0.0004
679 END STAGE RENAL DISEASE 7 0.0004
680 RESTLESSNESS 14 0.0004
681 PRODUCT USE COMPLAINT 6 0.0004
682 DYSURIA 14 0.0004
683 INJECTION SITE ERYTHEMA 47 0.0004
684 SARS-COV-2 TEST POSITIVE 5 0.0004
685 JOINT DISLOCATION 4 0.0004
686 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
687 EATING DISORDER 8 0.0004
688 BACTERIAL INFECTION 7 0.0004
689 IRRITABLE BOWEL SYNDROME 8 0.0004
690 DYSPNOEA EXERTIONAL 14 0.0004
691 DECREASED ACTIVITY 4 0.0004
692 PHARYNGITIS STREPTOCOCCAL 4 0.0004
693 BLOOD POTASSIUM INCREASED 6 0.0004
694 LUNG DISORDER 18 0.0004
695 ABNORMAL FAECES 3 0.0004
696 OESOPHAGITIS 4 0.0004
697 METASTASES TO BONE 6 0.0004
698 ERYTHEMA 75 0.0004
699 ESCHERICHIA INFECTION 3 0.0004
700 GLAUCOMA 7 0.0004
701 DRUG INTOLERANCE 35 0.0004
702 MALAISE 158 0.0004
703 EOSINOPHIL COUNT INCREASED 3 0.0004
704 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
705 DYSPNOEA 203 0.0004
706 APHONIA 5 0.0004
707 SURGERY 21 0.0004
708 SKIN FISSURES 7 0.0004
709 MASS 5 0.0004
710 EMOTIONAL DISORDER 11 0.0004
711 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
712 SKIN INFECTION 4 0.0004
713 MENORRHAGIA 7 0.0004
714 NEPHROPATHY TOXIC 4 0.0004
715 ACNE 27 0.0004
716 INTENTIONAL PRODUCT MISUSE 31 0.0004
717 LYMPHOPENIA 5 0.0004
718 MITRAL VALVE INCOMPETENCE 4 0.0004
719 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
720 APPLICATION SITE PRURITUS 8 0.0004
721 SWOLLEN TONGUE 11 0.0004
722 HAEMATURIA 12 0.0004
723 HYPERSENSITIVITY 65 0.0003
724 CARDIAC OPERATION 3 0.0003
725 TACHYCARDIA 31 0.0003
726 PRODUCT ADMINISTRATION ERROR 7 0.0003
727 DEVICE ISSUE 31 0.0003
728 INFECTION 50 0.0003
729 MOOD SWINGS 11 0.0003
730 NEUTROPHIL COUNT DECREASED 14 0.0003
731 INJECTION SITE PRURITUS 23 0.0003
732 BODY TEMPERATURE INCREASED 7 0.0003
733 PRODUCT USE ISSUE 64 0.0003
734 INJECTION SITE SWELLING 26 0.0003
735 PSYCHOTIC DISORDER 10 0.0003
736 SYSTEMIC LUPUS ERYTHEMATOSUS 12 0.0003
737 COLITIS ULCERATIVE 15 0.0003
738 GASTROINTESTINAL DISORDER 30 0.0003
739 GASTROINTESTINAL INFECTION 3 0.0003
740 ROAD TRAFFIC ACCIDENT 14 0.0003
741 MUSCLE RIGIDITY 4 0.0003
742 BONE LOSS 5 0.0003
743 PRESYNCOPE 8 0.0003
744 URTICARIA 55 0.0003
745 LOSS OF CONSCIOUSNESS 42 0.0003
746 INSURANCE ISSUE 5 0.0003
747 HAEMATOCHEZIA 18 0.0003
748 INJECTION SITE BRUISING 26 0.0003
749 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
750 INJECTION SITE MASS 12 0.0003
751 PRURITUS GENERALISED 7 0.0003
752 DEEP VEIN THROMBOSIS 21 0.0003
753 ANKLE FRACTURE 5 0.0003
754 PHARYNGITIS 4 0.0003
755 APPLICATION SITE IRRITATION 4 0.0003
756 DYSARTHRIA 12 0.0003
757 ABDOMINAL PAIN 74 0.0003
758 DIABETES MELLITUS 24 0.0003
759 ULCER 5 0.0003
760 DISEASE PROGRESSION 37 0.0003
761 HEPATITIS 8 0.0003
762 LOWER LIMB FRACTURE 6 0.0003
763 DRUG PRESCRIBING ERROR 6 0.0003
764 UNRESPONSIVE TO STIMULI 8 0.0003
765 PNEUMONIA 100 0.0003
766 CHOKING 6 0.0003
767 SUICIDAL IDEATION 28 0.0003
768 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
769 ANKYLOSING SPONDYLITIS 4 0.0003
770 PANCREATITIS 16 0.0003
771 PRODUCT QUALITY ISSUE 41 0.0003
772 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
773 ASTHMA 34 0.0003
774 PYREXIA 104 0.0003
775 VIRAL INFECTION 10 0.0003
776 AGITATION 22 0.0003
777 VAGINAL HAEMORRHAGE 13 0.0003
778 ANAEMIA 57 0.0003
779 BLOOD UREA INCREASED 5 0.0003
780 PRODUCT PHYSICAL ISSUE 6 0.0003
781 JAUNDICE 8 0.0003
782 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
783 INJECTION SITE PAIN 91 0.0003
784 SKIN EXFOLIATION 25 0.0003
785 BLOOD BILIRUBIN INCREASED 8 0.0003
786 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 21 0.0003
787 IMPAIRED GASTRIC EMPTYING 4 0.0003
788 LIVER DISORDER 13 0.0003
789 SCAR 5 0.0003
790 HALLUCINATION 22 0.0003
791 APPLICATION SITE RASH 4 0.0003
792 PARANOIA 5 0.0003
793 TOOTH LOSS 6 0.0003
794 VOMITING 136 0.0003
795 HUNGER 4 0.0003
796 WOUND 8 0.0003
797 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
798 MOUTH ULCERATION 6 0.0003
799 BLOOD TEST ABNORMAL 4 0.0003
800 INCORRECT DRUG ADMINISTRATION DURATION 8 0.0003
801 DEVICE OCCLUSION 4 0.0003
802 BREAST PAIN 3 0.0003
803 INTENTIONAL DOSE OMISSION 8 0.0003
804 BRONCHOSPASM 4 0.0003
805 PLEURAL EFFUSION 17 0.0003
806 SKIN CANCER 6 0.0003
807 GASTROENTERITIS VIRAL 5 0.0003
808 ANOSMIA 4 0.0003
809 BACK INJURY 3 0.0003
810 BONE DISORDER 5 0.0003
811 RENAL FAILURE 36 0.0003
812 COLON CANCER 4 0.0003
813 SNEEZING 6 0.0003
814 RESPIRATORY DISORDER 8 0.0003
815 CARDIAC DISORDER 25 0.0003
816 OXYGEN SATURATION DECREASED 15 0.0003
817 HYPONATRAEMIA 15 0.0003
818 SKIN BURNING SENSATION 19 0.0003
819 PULMONARY EMBOLISM 25 0.0003
820 DERMATITIS CONTACT 3 0.0003
821 INCORRECT DOSE ADMINISTERED 60 0.0003
822 RENAL IMPAIRMENT 22 0.0003
823 GASTRIC HAEMORRHAGE 3 0.0003
824 PULMONARY FIBROSIS 5 0.0003
825 PERICARDIAL EFFUSION 6 0.0003
826 DRUG INTERACTION 41 0.0003
827 ELECTROLYTE IMBALANCE 3 0.0003
828 RENAL DISORDER 12 0.0003
829 LUNG INFECTION 4 0.0003
830 EJECTION FRACTION DECREASED 4 0.0003
831 PALLOR 7 0.0003
832 BONE DENSITY DECREASED 8 0.0003
833 SICKLE CELL ANAEMIA WITH CRISIS 4 0.0003
834 DISABILITY 5 0.0003
835 ACCIDENT 3 0.0003
836 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
837 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
838 ILL-DEFINED DISORDER 15 0.0002
839 DYSKINESIA 10 0.0002
840 CARDIOMEGALY 3 0.0002
841 MANIA 4 0.0002
842 DRUG LEVEL INCREASED 4 0.0002
843 INFUSION RELATED REACTION 16 0.0002
844 SYNCOPE 24 0.0002
845 CARDIAC FAILURE CONGESTIVE 19 0.0002
846 HEMIPARESIS 4 0.0002
847 CIRCULATORY COLLAPSE 4 0.0002
848 SEIZURE 27 0.0002
849 SEPSIS 26 0.0002
850 UNDERDOSE 17 0.0002
851 FAECES DISCOLOURED 5 0.0002
852 ORTHOSTATIC HYPOTENSION 4 0.0002
853 PRODUCT DISPENSING ERROR 5 0.0002
854 DEAFNESS 6 0.0002
855 HYPOXIA 8 0.0002
856 ABNORMAL BEHAVIOUR 9 0.0002
857 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
858 INJECTION SITE HAEMORRHAGE 18 0.0002
859 HEPATOTOXICITY 5 0.0002
860 MENSTRUATION IRREGULAR 6 0.0002
861 PRODUCT ADHESION ISSUE 8 0.0002
862 EXTRA DOSE ADMINISTERED 9 0.0002
863 SYNOVITIS 4 0.0002
864 BLINDNESS 9 0.0002
865 DRUG INEFFECTIVE 291 0.0002
866 NEUTROPENIA 30 0.0002
867 HAEMORRHAGE 23 0.0002
868 MENTAL STATUS CHANGES 6 0.0002
869 RHABDOMYOLYSIS 9 0.0002
870 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
871 OSTEONECROSIS 7 0.0002
872 FRACTURE 4 0.0002
873 ARRHYTHMIA 10 0.0002
874 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
875 DISEASE RECURRENCE 10 0.0002
876 RECTAL HAEMORRHAGE 9 0.0002
877 TYPE 2 DIABETES MELLITUS 7 0.0002
878 BLOOD GLUCOSE INCREASED 39 0.0002
879 PRESCRIBED OVERDOSE 4 0.0002
880 LIVER FUNCTION TEST ABNORMAL 6 0.0002
881 FLUID OVERLOAD 3 0.0002
882 GASTROENTERITIS 3 0.0002
883 GASTROINTESTINAL HAEMORRHAGE 17 0.0002
884 OEDEMA 11 0.0002
885 HAEMATOCRIT DECREASED 4 0.0002
886 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
887 PULMONARY OEDEMA 9 0.0002
888 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
889 HAEMORRHAGE INTRACRANIAL 3 0.0002
890 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
891 HYPOTENSION 40 0.0002
892 CARDIAC FAILURE 16 0.0002
893 PRODUCT USE IN UNAPPROVED INDICATION 49 0.0002
894 PRODUCT COMPLAINT 5 0.0002
895 DEVICE FAILURE 3 0.0002
896 DRUG DISPENSING ERROR 3 0.0002
897 DRUG ADMINISTRATION ERROR 6 0.0002
898 MALIGNANT NEOPLASM PROGRESSION 20 0.0002
899 DEVICE RELATED INFECTION 3 0.0002
900 CYANOSIS 3 0.0002
901 INCORRECT DOSE ADMINISTERED BY DEVICE 5 0.0002
902 HALLUCINATION, VISUAL 4 0.0002
903 HALLUCINATION, AUDITORY 3 0.0002
904 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 38 0.0002
905 MENTAL DISORDER 8 0.0002
906 BLOOD CREATININE INCREASED 12 0.0002
907 PNEUMONITIS 5 0.0002
908 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
909 ANGIOEDEMA 8 0.0002
910 VISUAL ACUITY REDUCED 6 0.0002
911 EXPIRED PRODUCT ADMINISTERED 6 0.0002
912 LEUKOPENIA 9 0.0002
913 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
914 SKIN IRRITATION 8 0.0002
915 ANGINA PECTORIS 5 0.0002
916 CEREBROVASCULAR ACCIDENT 29 0.0002
917 ACUTE KIDNEY INJURY 26 0.0002
918 ACUTE MYOCARDIAL INFARCTION 5 0.0002
919 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
920 PRODUCT PRESCRIBING ERROR 4 0.0002
921 THERAPEUTIC RESPONSE DECREASED 10 0.0002
922 INJECTION SITE RASH 5 0.0002
923 ANAPHYLACTIC REACTION 9 0.0002
924 ENCEPHALOPATHY 4 0.0002
925 BLOOD GLUCOSE ABNORMAL 3 0.0002
926 OSTEONECROSIS OF JAW 4 0.0002
927 MYOCARDIAL INFARCTION 28 0.0002
928 TOXICITY TO VARIOUS AGENTS 27 0.0002
929 DRUG-INDUCED LIVER INJURY 5 0.0002
930 HAEMATEMESIS 4 0.0002
931 DEVICE MALFUNCTION 11 0.0002
932 ERECTILE DYSFUNCTION 4 0.0002
933 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 28 0.0002
934 ILLNESS 16 0.0002
935 OFF LABEL USE 134 0.0002
936 THROMBOCYTOPENIA 17 0.0002
937 NEOPLASM MALIGNANT 10 0.0001
938 BREAST CANCER FEMALE 4 0.0001
939 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
940 BONE MARROW FAILURE 3 0.0001
941 LUNG NEOPLASM MALIGNANT 6 0.0001
942 CARDIAC ARREST 12 0.0001
943 HAEMOPTYSIS 4 0.0001
944 HOSPITALISATION 22 0.0001
945 DERMATITIS 3 0.0001
946 DEMENTIA 4 0.0001
947 THERAPY INTERRUPTED 10 0.0001
948 DEVICE LEAKAGE 6 0.0001
949 ECZEMA 7 0.0001
950 CORONARY ARTERY DISEASE 4 0.0001
951 COVID-19 23 0.0001
952 BREAST CANCER 12 0.0001
953 BLOOD GLUCOSE DECREASED 6 0.0001
954 AGGRESSION 6 0.0001
955 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001
956 ANAPHYLACTIC SHOCK 3 0.0001
957 HAEMATOMA 3 0.0001
958 BRADYCARDIA 6 0.0001
959 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
960 FEBRILE NEUTROPENIA 7 0.0001
961 PRODUCT DOSE OMISSION ISSUE 31 0.0001
962 CONVULSION 6 0.0001
963 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
964 GENERAL PHYSICAL HEALTH DETERIORATION 12 0.0001
965 INTERSTITIAL LUNG DISEASE 5 0.0001
966 DEATH 88 0.0001
967 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
968 RESPIRATORY FAILURE 7 0.0001
969 OVERDOSE 20 0.0001
970 SEPTIC SHOCK 4 0.0001
971 TREATMENT NONCOMPLIANCE 5 0.0001
972 PRODUCT STORAGE ERROR 8 0.0001
973 ADVERSE EVENT 8 0.0001
974 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
975 INJURY 6 0.0001
976 CEREBRAL HAEMORRHAGE 3 0.0001
977 HYPOGLYCAEMIA 4 0.0001
978 C-REACTIVE PROTEIN INCREASED 3 0.0001
979 DRUG WITHDRAWAL SYNDROME 7 0.0001
980 DEVICE BREAKAGE 3 0.0001
981 MEDICATION ERROR 4 0.0001
982 DEVICE DISLOCATION 3 0.0001
983 BLADDER CANCER 4 0.0001
984 COMA 3 0.0001
985 PROSTATE CANCER 5 0.0001
986 TREATMENT FAILURE 5 0.0001
987 DRUG DOSE OMISSION BY DEVICE 4 0.0001
988 EMOTIONAL DISTRESS 6 0.0000
989 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
990 DRUG DEPENDENCE 5 0.0000